Successful immunoglobulin treatment in a case of epileptic encephalopathy

Area of Science:

• Pediatric Neurology
• Neuroimmunology
• Epileptology

Background:

• Epileptic encephalopathy can present with severe psychomotor regression.
• Autoimmune causes, particularly anti-glutamate receptor antibody encephalitis, are increasingly recognized.
• Standard antiepileptic drugs may be ineffective in autoimmune-related epilepsy.

Observation:

• A 6-year-old boy with normal development experienced refractory tonic-clonic seizures and myoclonus, leading to psychomotor regression.
• Elevated anti-glutamate receptor antibodies (anti-GluR) in cerebrospinal fluid and serum suggested an autoimmune etiology.
• Conventional antiepileptic drugs were ineffective in controlling the patient's seizures.

Findings:

• Intravenous immunoglobulin therapy led to a dramatic reduction in seizure frequency.
• The patient showed remarkable improvement in motor skills, including unaided walking, and cognitive functions, with speech recovery.
• This response strongly supports an autoimmune pathogenesis and the efficacy of immunotherapy.

Implications:

• Immunoglobulin treatment should be strongly considered for pediatric patients presenting with subacute-onset, progressive epileptic encephalopathy of unknown cause.
• This case highlights the importance of screening for autoimmune markers in refractory epilepsy.
• Early diagnosis and immunotherapy can significantly alter the disease course and improve long-term outcomes in autoimmune-mediated epilepsy.